» Articles » PMID: 23619945

Polymorphisms in DNA Repair Pathway Genes, Body Mass Index, and Risk of Non-Hodgkin Lymphoma

Abstract

We conducted a population-based case-control study in Connecticut women to test the hypothesis that genetic variations in DNA repair pathway genes may modify the relationship between body mass index (BMI) and risk of non-Hodgkin lymphoma (NHL). Compared to those with BMI <25, women with BMI ≥25 had significantly increased risk of NHL among women who carried BRCA1 (rs799917) CT/TT, ERCC2 (rs13181) AA, XRCC1 (rs1799782) CC, and WRN (rs1801195) GG genotypes, but no increase in NHL risk among women who carried BRCA1 CC, ERCC2 AC/CC, XRCC1 CT/TT, and WRN GT/TT genotypes. A significant interaction with BMI was only observed for WRN (rs1801195; P = 0.004) for T-cell lymphoma and ERCC2 (rs13181; P = 0.002) for diffuse large B-cell lymphoma. The results suggest that common genetic variation in DNA repair pathway genes may modify the association between BMI and NHL risk.

Citing Articles

The Role of DNA Repair (, , , and Gene Polymorphisms in the Development of Myeloproliferative Neoplasms.

Crisan A, Tripon F, Boglis A, Crauciuc G, Trifa A, Lazar E Medicina (Kaunas). 2024; 60(3).

PMID: 38541232 PMC: 10972134. DOI: 10.3390/medicina60030506.


Screening of BRCA1 variants c.190T>C, 1307delT, g.5331G>A and c.2612C>T in breast cancer patients from North India.

Kour A, Sambyal V, Guleria K, Singh N, Uppal M, Manjari M Genet Mol Biol. 2020; 43(2):e20190014.

PMID: 32453341 PMC: 7250277. DOI: 10.1590/1678-4685-GMB-2019-0014.


Novel Associations between BRCA1 Variants C.181 T>G (Rs28897672) and Ovarian Crisk in Saudi Females.

Alyahri N, Abdi S, Khan W, Elrobh M, Addar M, Babay Z J Med Biochem. 2019; 38(1):13-21.

PMID: 30820179 PMC: 6298454. DOI: 10.2478/jomb-2018-0037.


Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma.

Tong Y, Xiang Y, Li B, Bao S, Zhou Y, Yuan W Med Sci Monit. 2018; 24:7015-7022.

PMID: 30279407 PMC: 6179170. DOI: 10.12659/MSM.908813.


Association between BRCA1 P871L polymorphism and cancer risk: evidence from a meta-analysis.

Miao L, Yu Y, Ji Y, Zhang B, Yuan Z, Du Y Oncotarget. 2017; 8(18):30587-30594.

PMID: 28427168 PMC: 5444767. DOI: 10.18632/oncotarget.15739.


References
1.
Samanic C, Chow W, Gridley G, Jarvholm B, Fraumeni Jr J . Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006; 17(7):901-9. DOI: 10.1007/s10552-006-0023-9. View

2.
Povey A, Margison G, Santibanez-Koref M . Lung cancer risk and variation in MGMT activity and sequence. DNA Repair (Amst). 2007; 6(8):1134-44. DOI: 10.1016/j.dnarep.2007.03.022. View

3.
Bahl S, Cotterchio M, Kreiger N, Klar N . Antidepressant medication use and non-Hodgkin's lymphoma risk: no association. Am J Epidemiol. 2004; 160(6):566-75. DOI: 10.1093/aje/kwh234. View

4.
Cerhan J, Bernstein L, Severson R, Davis S, Colt J, Blair A . Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma. Cancer Causes Control. 2005; 16(10):1203-14. DOI: 10.1007/s10552-005-0358-7. View

5.
Radak Z, Kaneko T, Tahara S, Nakamoto H, Ohno H, Sasvari M . The effect of exercise training on oxidative damage of lipids, proteins, and DNA in rat skeletal muscle: evidence for beneficial outcomes. Free Radic Biol Med. 1999; 27(1-2):69-74. DOI: 10.1016/s0891-5849(99)00038-6. View